DnB Asset Management’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $608K | Buy |
53,983
+5,504
| +11% | +$62K | ﹤0.01% | 640 |
|
|
2025
Q1 | $489K | Buy |
48,479
+3,802
| +9% | +$38.4K | ﹤0.01% | 657 |
|
|
2024
Q4 | $529K | Sell |
44,677
-7,531
| -14% | -$89.1K | ﹤0.01% | 660 |
|
|
2024
Q3 | $602K | Sell |
52,208
-3,814
| -7% | -$44K | ﹤0.01% | 650 |
|
|
2024
Q2 | $592K | Buy |
56,022
+3,386
| +6% | +$35.8K | ﹤0.01% | 643 |
|
|
2024
Q1 | $555K | Buy |
52,636
+796
| +2% | +$8.4K | ﹤0.01% | 648 |
|
|
2023
Q4 | $582K | Buy |
51,840
+5,700
| +12% | +$64K | ﹤0.01% | 625 |
|
|
2023
Q3 | $540K | Sell |
46,140
-11,303
| -20% | -$132K | ﹤0.01% | 632 |
|
|
2023
Q2 | $579K | Buy |
+57,443
| New | +$579K | ﹤0.01% | 627 |
|